EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Testicular cancer in 2023: Current status and recent progress

Deaglan J McHugh iD, Jack P Gleeson iD, Darren R Feldman

CA: A Cancer Journal for Clinicians · 2024-03 · 74 (2) · 167-186

DOI: 10.3322/caac.21819 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift CA: A Cancer Journal for Clinicians, online erschienen am 10.11.2023. Verfasst von Deaglan J McHugh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Testicular Neoplasms, Neoplasms, Germ Cell and Embryonal. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Testicular germ cell tumor (GCT) is the most common solid tumor in adolescent and young adult men. Progress in the management of GCT has been made in the last 50 years, with a substantial improvement in cure rates for advanced disease, from 25% in the 1970s to nearly 80%. However, relapsed or platinum‐refractory disease occurs in a proportion, 20% of whom will die from disease progression. This article reviews the current evidence‐based treatments for extracranial GCT, the acute and chronic toxic effects that may result, and highlights contemporary advances and progress in the field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Testicular NeoplasmsNeoplasms, Germ Cell and EmbryonalMaleAdolescentYoung AdultHumansAntineoplastic Combined Chemotherapy Protocols

Stichwörter der Autor:innen

advancedchemotherapyclinical trialsgerm cell tumortesticular cancer

Autor:innen und Institutionen

  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Weill Cornell Medicine, New York, New York, USA.
  • Cancer Research, College of Medicine and Health, University College Cork, Cork, Ireland.
  • Medical Oncology Department, Cork University Hospital, Cork, Ireland.

ORCID-Profile: Deaglan J McHugh, Jack P Gleeson

Zitieren

APA

McHugh, D. J., Gleeson, J. P., & Feldman, D. R. (2024). Testicular cancer in 2023: Current status and recent progress. CA: A Cancer Journal for Clinicians, 74(2), 167-186. https://doi.org/10.3322/caac.21819

Vancouver

McHugh DJ, Gleeson JP, Feldman DR. Testicular cancer in 2023: Current status and recent progress. CA: A Cancer Journal for Clinicians. 2024;74(2):167-186. doi:10.3322/caac.21819

BibTeX
@article{McHugh2024,
  author = {McHugh, Deaglan J and Gleeson, Jack P and Feldman, Darren R},
  title = {Testicular cancer in 2023: Current status and recent progress},
  journal = {CA: A Cancer Journal for Clinicians},
  year = {2024},
  volume = {74},
  number = {2},
  pages = {167--186},
  doi = {10.3322/caac.21819}
}
Kostenlos starten →